These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Author: Becker T, Struck M, Laux G.
    Journal: Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856.
    Abstract:
    In an open study 13 depressed inpatients received moclobemide, a selective and reversible MAO-A-inhibitor (300 mg/d) for one week and subsequently were switched to a three-week course of a tricyclic or tetracyclic antidepressant (TCA) without medication-free interval. There were no drop-out, two patients needed additional ECT. Depressive symptomatology declined during treatment which was well tolerated. Mild adverse CNS effects and gastrointestinal symptoms prevailed under moclobemide. Subsequent TCA prompted autonomic symptoms. Overall adverse drug effects decreased over the treatment period. Cardiovascular monitoring revealed no clinically relevant side effects.
    [Abstract] [Full Text] [Related] [New Search]